Matthew Bordbari, DO | |
Helix: 30 N Mario Capecchi Dr Rm 5n223, Salt Lake City, UT 84112 | |
(801) 581-2121 | |
Not Available |
Full Name | Matthew Bordbari |
---|---|
Gender | Male |
Speciality | Anesthesiology - Critical Care Medicine |
Location | Helix: 30 N Mario Capecchi Dr Rm 5n223, Salt Lake City, Utah |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851970735 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 20820 (California) | Secondary |
207LC0200X | Anesthesiology - Critical Care Medicine | 13930740-1204 (Utah) | Primary |
Entity Name | Cep America - California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Allergan, Inc. today announced operating results for the quarter ended June 30, 2010. Allergan also announced that its Board of Directors has declared a second quarter dividend of $0.05 per share, payable on September 7, 2010 to stockholders of record on August 17, 2010.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
Ahead of the Rio+20 U.N. Conference on Sustainable Development, "CGIAR, the world's largest publicly funded research body, has published a seven-point 'call to action' plan," which "calls for an improved commitment to deliver nutrition security and lessen the need to aid," BBC News reports.
The search for a stable, renewable source of blood vessels, especially for potential use in heart bypass surgery, has reached a milestone at the State University of New York at Buffalo.
According to new clinical data presented today at ACC.12 - the 61st Annual Scientific Session & Expo of the American College of Cardiology (ACC) - the Resolute drug-eluting stent (DES) from Medtronic, Inc. maintains a powerful and persistent treatment effect for a wide variety of patients with coronary artery disease, including those with diabetes mellitus, through two years of follow-up.
› Verified 2 days ago
Entity Name | Cep America - California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
Allergan, Inc. today announced operating results for the quarter ended June 30, 2010. Allergan also announced that its Board of Directors has declared a second quarter dividend of $0.05 per share, payable on September 7, 2010 to stockholders of record on August 17, 2010.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
Ahead of the Rio+20 U.N. Conference on Sustainable Development, "CGIAR, the world's largest publicly funded research body, has published a seven-point 'call to action' plan," which "calls for an improved commitment to deliver nutrition security and lessen the need to aid," BBC News reports.
The search for a stable, renewable source of blood vessels, especially for potential use in heart bypass surgery, has reached a milestone at the State University of New York at Buffalo.
According to new clinical data presented today at ACC.12 - the 61st Annual Scientific Session & Expo of the American College of Cardiology (ACC) - the Resolute drug-eluting stent (DES) from Medtronic, Inc. maintains a powerful and persistent treatment effect for a wide variety of patients with coronary artery disease, including those with diabetes mellitus, through two years of follow-up.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Matthew Bordbari, DO Helix: 30 N Mario Capecchi Dr Rm 5n223, Salt Lake City, UT 84112 Ph: (801) 581-2121 | Matthew Bordbari, DO Helix: 30 N Mario Capecchi Dr Rm 5n223, Salt Lake City, UT 84112 Ph: (801) 581-2121 |
News Archive
Allergan, Inc. today announced operating results for the quarter ended June 30, 2010. Allergan also announced that its Board of Directors has declared a second quarter dividend of $0.05 per share, payable on September 7, 2010 to stockholders of record on August 17, 2010.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
Ahead of the Rio+20 U.N. Conference on Sustainable Development, "CGIAR, the world's largest publicly funded research body, has published a seven-point 'call to action' plan," which "calls for an improved commitment to deliver nutrition security and lessen the need to aid," BBC News reports.
The search for a stable, renewable source of blood vessels, especially for potential use in heart bypass surgery, has reached a milestone at the State University of New York at Buffalo.
According to new clinical data presented today at ACC.12 - the 61st Annual Scientific Session & Expo of the American College of Cardiology (ACC) - the Resolute drug-eluting stent (DES) from Medtronic, Inc. maintains a powerful and persistent treatment effect for a wide variety of patients with coronary artery disease, including those with diabetes mellitus, through two years of follow-up.
› Verified 2 days ago
Dr. Anne Wierman Estares, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E, Rm 4c104, Salt Lake City, UT 84132 Phone: 719-314-5254 | |
Ashley Nicole Langell, MS, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 3c444, Salt Lake City, UT 84132 Phone: 801-581-3622 | |
Dr. Nicole Jeffreys, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 100 Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-3578 | |
Matthew L Peterson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1200 E 3900 S, Salt Lake City, UT 84124 Phone: 801-993-9530 Fax: 801-733-5618 | |
Dr. Jeffrey David Dillon, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E, Room 3c444, Salt Lake City, UT 84132 Phone: 801-581-6393 Fax: 801-581-4367 | |
Jennifer Jean Davis, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-6393 | |
Dennis L. Morris, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1200 E 3900 S, Salt Lake City, UT 84124 Phone: 801-993-9530 Fax: 801-733-5618 |